Latest news
Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS - MarketBeatMarketBeat · Thu, 06 Aug 2026 04:22:53 GMTRoyalty Pharma (RPRX) Stock Revenue Strength Masks Thin Earnings - simplywall.stsimplywall.st · Thu, 06 Aug 2026 04:22:13 GMTRoyalty Pharma Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 19:04:02 GMTRoyalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 19:01:29 GMTRoyalty Pharma raises 2026 revenue forecast aft... - PluangPluang · Wed, 05 Aug 2026 15:07:26 GMTRPRX: Q2 2026 saw double-digit growth, raised guidance, and robust capital deployment - TradingViewTradingView · Wed, 05 Aug 2026 14:35:39 GMTRoyalty Pharma reports Q2 2026: Portfolio Receipts $773M, Royalty Receipts up 14% - TradingViewTradingView · Wed, 05 Aug 2026 11:43:03 GMTRPRX: Double-digit growth, strong returns, and robust portfolio expansion define Q2 2026 - TradingViewTradingView · Wed, 05 Aug 2026 11:33:28 GMT